John Theurer Cancer Center, Hackensack University Medical Center
John Theurer Cancer Center at Hackensack University Medical Center is New Jersey’s largest and most comprehensive cancer program. More people in the New Jersey/New York metropolitan area turn to John Theurer Cancer Center for cancer care each year than to any other facility in New Jersey for comprehensive bone marrow and stem cell transplant program, expertise in the management of hematologic malignancies in adults and children, robust clinical trial portfolio etc.
The treatment of multiple myeloma is highly personalized at John Theurer Cancer Center, part of Hackensack University Medical Center in New Jersey. Some people have diseases that have the potential to turn into multiple myeloma. These “precursor” disorders include smoldering multiple myeloma and monoclonal gammopathy of undetermined significance (MGUS). If you were diagnosed with one of these disorders, you may have been surprised because they don’t cause any symptoms. Our doctors take a conservative approach to treating patients with smoldering multiple myeloma and MGUS. We’ll monitor you and let you know if or when you may benefit from treatment.
John Theurer Cancer Center is one of the few sites offering chimeric antigen receptor (CAR) T-cell therapy, a highly promising form of personalized immunotherapy for certain blood cancers and has been involved in CAR T-cell research for nearly a decade.
